 - Patients who are diagnosed with human immunodeficiency virus-type 1 HIV-1, and who are eligible for darunavir in combination with ritonavir treatment. These may be either: treatment-naive adult patients and treatment-experienced adult patients with no darunavir resistance associated substitutions; or treatment-experienced adult patients with at least one darunavir resistance associated substitution 